Well said. Thank you so much ohm.
I also would like to believe that she is no longer on the panel.
Given what is now happening at SEC and DOJ, the FDA would probably do what you've said and recuse her, so as to start fresh without dirty laundry.
On the plus side the clinicians, scientists and statisticians are going to base their recommendations on the evidence. If an RPM goes against their advice there might be hell to pay.
and we know what the evidence says already. Safety, Efficacy and Multi-faceted functionality. That is what we own.